{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T12:52:42Z","timestamp":1784983962753,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1245\/s10434-025-18096-w","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:19:40Z","timestamp":1758813580000},"page":"9668-9675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Utility of Preoperative PET\/CT in Patients with Clinically High-Risk Melanoma"],"prefix":"10.1245","volume":"32","author":[{"given":"Emily","family":"Papai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Ntoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian Q.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Olszanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Villano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S.","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay S.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Farma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie H.","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"18096_CR1","unstructured":"National Cancer Institute. (2018). Melanoma of the Skin \u2013 Cancer Stat Facts. SEER. https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html"},{"issue":"2","key":"18096_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1245\/s10434-015-4894-4","volume":"23","author":"DE Gyorki","year":"2016","unstructured":"Gyorki DE, Sanelli A, Herschtal A, et al. Sentinel lymph node biopsy in t4 melanoma: an important risk-stratification tool. Ann Surg Oncol. 2016;23(2):579\u201384. https:\/\/doi.org\/10.1245\/s10434-015-4894-4.","journal-title":"Ann Surg Oncol."},{"key":"18096_CR3","unstructured":"Cleveland Clinic. (2022). PET Scan \/ Cleveland Clinic. Cleveland Clinic. https:\/\/my.clevelandclinic.org\/health\/diagnostics\/10123-pet-scan"},{"key":"18096_CR4","doi-asserted-by":"publisher","first-page":"107327482412273","DOI":"10.1177\/10732748241227340","volume":"31","author":"J Yuan","year":"2024","unstructured":"Yuan J, Li X, Yu S. Global, regional, and national incidence trend analysis of malignant skin melanoma between 1990 and 2019, and projections until 2034. Cancer Control. 2024;31:10732748241227340.","journal-title":"Cancer Control"},{"issue":"4","key":"18096_CR5","first-page":"63","volume":"9","author":"K Saginala","year":"2021","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. Epidemiology of melanoma. Med Sci. 2021;9(4):63.","journal-title":"Med Sci."},{"issue":"19","key":"18096_CR6","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.3390\/cancers14194652","volume":"14","author":"J Lopes","year":"2022","unstructured":"Lopes J, Rodrigues CM, Gaspar MM, Reis CP. Melanoma management: from epidemiology to treatment and latest advances. Cancers. 2022;14(19):4652.","journal-title":"Cancers."},{"issue":"6","key":"18096_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/jcm13061607","volume":"13","author":"AJ Dixon","year":"2024","unstructured":"Dixon AJ, Sladden M, Zouboulis CC, Popescu CM, Nirenberg A, Steinman HK, Thomas JM. Primary cutaneous melanoma\u2014management in 2024. J Clin Med. 2024;13(6):160.","journal-title":"J Clin Med."},{"key":"18096_CR8","doi-asserted-by":"crossref","unstructured":"Arrangoiz, R., Papavasiliou, P., Stransky, C. A., Yu, J. Q., Tianyu, L., Sigurdson, E. R., ... & Farma, J. M. (2012). Preoperative FDG-PET\/CT is an important tool in the management of patients with thick (T4) melanoma.\u00a0Dermatol Res Pract.,\u00a02012","DOI":"10.1155\/2012\/614349"},{"issue":"3","key":"18096_CR9","first-page":"245","volume":"29","author":"MI Longo","year":"2003","unstructured":"Longo MI, La \u0301zaro P, Bueno C, Carreras JL, Montz R. Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients. Dermatol Surg. 2003;29(3):245\u20138.","journal-title":"Dermatol Surg."},{"issue":"4","key":"18096_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.0007-0963.2004.05870.x","volume":"150","author":"J Hafner","year":"2004","unstructured":"Hafner J, Hess Schmid M, Kempf W, et al. Baseline staging in cutaneous malignant melanoma. Br J Dermatol. 2004;150(4):677\u201386.","journal-title":"Br J Dermatol."},{"issue":"5","key":"18096_CR11","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1200\/JCO.1999.17.5.1508","volume":"17","author":"JD Wagner","year":"1999","unstructured":"Wagner JD, Schauwecker D, Davidson D, et al. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients under- going sentinel node biopsy. J Clin Oncol. 1999;17(5):1508\u201315.","journal-title":"J Clin Oncol."},{"issue":"10","key":"18096_CR12","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1200\/JCO.2001.19.10.2674","volume":"19","author":"KM Acland","year":"2001","unstructured":"Acland KM, Healy C, Calonje E, et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol. 2001;19(10):2674\u20138.","journal-title":"J Clin Oncol."},{"issue":"2","key":"18096_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00008390-200404000-00011","volume":"14","author":"AM Fink","year":"2004","unstructured":"Fink AM, Holle-Robatsch S, Herzog N, et al. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II. Melanoma Res. 2004;14(2):141\u20135.","journal-title":"Melanoma Res."},{"issue":"8","key":"18096_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0748-7983(03)00147-1","volume":"29","author":"K Havenga","year":"2003","unstructured":"Havenga K, Cobben DCP, Oyenetal WJG. Fluorodeoxyglycose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol. 2003;29(8):662\u20134.","journal-title":"Eur J Surg Oncol."},{"issue":"9","key":"18096_CR15","first-page":"1491","volume":"41","author":"F Crippa","year":"2000","unstructured":"Crippa F, Leutner M, Belli F, et al. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med. 2000;41(9):1491\u20134.","journal-title":"J Nucl Med."},{"issue":"6","key":"18096_CR16","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1001\/jamadermatol.2019.0440","volume":"155","author":"LA von Schuckmann","year":"2019","unstructured":"von Schuckmann LA, Hughes MCB, Ghiasvand R, Malt M, van der Pols JC, Beesley VL, Khosrotehrani K, Smithers BM, Green AC. Risk of melanoma recurrence after diagnosis of a high-risk primary tumor. JAMA Dermatol. 2019;155(6):688\u201393. https:\/\/doi.org\/10.1001\/jamadermatol.2019.0440.","journal-title":"JAMA Dermatol."},{"issue":"5","key":"18096_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.36849\/JDD.7667","volume":"23","author":"MY Huang","year":"2024","unstructured":"Huang MY, Chen A, Quarshie C, Masson R, Barajas G, Kim G, DeClerck B, Swanson MS, In GK, Kokot N, Pickering TA, Hu JC. Influence of anatomic locations of T1b melanomas and patient age on outcomes. J Drug Dermatol JDD. 2024;23(5):306\u201310. https:\/\/doi.org\/10.36849\/JDD.7667.","journal-title":"J Drug Dermatol JDD."},{"issue":"17","key":"18096_CR18","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.2174\/0929867326666191205160007","volume":"27","author":"M Strudel","year":"2020","unstructured":"Strudel M, Festino L, Vanella V, Beretta M, Marincola FM, Ascierto PA. Melanoma: prognostic factors and factors predictive of response to therapy. Curr Med Chem. 2020;27(17):2792\u2013813. https:\/\/doi.org\/10.2174\/0929867326666191205160007.","journal-title":"Curr Med Chem"},{"issue":"3","key":"18096_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.det.2012.04.008","volume":"30","author":"OJ Wisco","year":"2012","unstructured":"Wisco OJ, Sober AJ. Prognostic factors for melanoma. Dermatol Clin. 2012;30(3):469\u201385. https:\/\/doi.org\/10.1016\/j.det.2012.04.008.","journal-title":"Dermatol Clin"},{"issue":"4","key":"18096_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/107327480501200403","volume":"12","author":"J Homsi","year":"2005","unstructured":"Homsi J, Kashani-Sabet M, Messina JL, Daud A. Cutaneous melanoma: prognostic factors. Cancer Control J Moffitt Cancer Center. 2005;12(4):223\u20139. https:\/\/doi.org\/10.1177\/107327480501200403.","journal-title":"Cancer Control J Moffitt Cancer Center."},{"issue":"2","key":"18096_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/2000656X.2020.1842746","volume":"55","author":"HP Gullestad","year":"2021","unstructured":"Gullestad HP, Haugen G, Foss\u00e5 SD. Late arm and shoulder problems after axillary therapeutic lymph node dissection in patients with melanoma. J Plast Surg Hand Surg. 2021;55(2):127\u201331. https:\/\/doi.org\/10.1080\/2000656X.2020.1842746.","journal-title":"J Plast Surg Hand Surg."},{"issue":"2","key":"18096_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00000658-199008000-00002","volume":"212","author":"RG Bevilacqua","year":"1990","unstructured":"Bevilacqua RG, Coit DG, Rogatko A, Younes RN, Brennan MF. Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg. 1990;212(2):125\u201331. https:\/\/doi.org\/10.1097\/00000658-199008000-00002.","journal-title":"Ann Surg."},{"issue":"5","key":"18096_CR23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/01.sla.0000143271.32568.2b","volume":"240","author":"EC Starritt","year":"2004","unstructured":"Starritt EC, Joseph D, McKinnon JG, Lo SK, de Wilt JH, Thompson JF. Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition. Ann Surg. 2004;240(5):866\u201374.","journal-title":"Ann Surg."},{"issue":"9","key":"18096_CR24","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1056\/NEJMoa2211437","volume":"388","author":"SP Patel","year":"2023","unstructured":"Patel SP, Othus M, Chen Y, Wright GP Jr, Yost KJ, Hyngstrom JR, Ribas A. Neoadjuvant\u2013adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N Engl J Med. 2023;388(9):813\u201323.","journal-title":"N Engl J Med."},{"issue":"7","key":"18096_CR25","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S1470-2045(19)30151-2","volume":"20","author":"EA Rozeman","year":"2019","unstructured":"Rozeman EA, Menzies AM, van Akkooi AC, Adhikari C, Bierman C, van de Wiel BA, Blank CU. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial. Lancet Oncol. 2019;20(7):948\u201360.","journal-title":"Lancet Oncol."},{"key":"18096_CR26","unstructured":"Blank, C. U., Lucas, M. W., Scolyer, R. A., van de Wiel, B. A., Menzies, A. M., Lopez-Yurda, M., & Long, G. V. (2024). Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma. N Engl J Med"},{"issue":"3","key":"18096_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1001\/archsurg.141.3.284","volume":"141","author":"PB Clark","year":"2006","unstructured":"Clark PB, Soo V, Kraas J, Shen P, Levine EA. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Arch Surg (Chicago, Ill: 1960). 2006;141(3):284\u20138. https:\/\/doi.org\/10.1001\/archsurg.141.3.284.","journal-title":"Arch Surg (Chicago, Ill.: 1960)."},{"issue":"5","key":"18096_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.rcl.2013.06.004","volume":"51","author":"AC Bourgeois","year":"2013","unstructured":"Bourgeois AC, Chang TT, Fish LM, Bradley YC. Positron emission tomography\/computed tomography in melanoma. Radiol Clin N Am. 2013;51(5):865\u201379. https:\/\/doi.org\/10.1016\/j.rcl.2013.06.004.","journal-title":"Radiol Clin N Am"},{"key":"18096_CR29","doi-asserted-by":"publisher","unstructured":"Dinnes J, Ferrante di Ruffano L, Takwoingi Y, et al. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.\u00a0Cochrane Database Syst Rev. 2019;7(7):CD012806. Published 2019 Jul 1. https:\/\/doi.org\/10.1002\/14651858.CD012806.pub2","DOI":"10.1002\/14651858.CD012806.pub2"},{"issue":"5","key":"18096_CR30","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.ejso.2020.12.007","volume":"47","author":"EHA Stahlie","year":"2021","unstructured":"Stahlie EHA, van der Hiel B, Bruining A, et al. The value of lymph node ultrasound and whole body 18F-FDG PET\/CT in stage IIB\/C melanoma patients prior to SLNB. Eur J Surg Oncol. 2021;47(5):1157\u201362. https:\/\/doi.org\/10.1016\/j.ejso.2020.12.007.","journal-title":"Eur J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18096-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18096-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18096-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:18:33Z","timestamp":1762352313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18096-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["18096"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18096-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}